These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1199 related articles for article (PubMed ID: 34352201)

  • 1. Prevalence and Predictors of Persistence of COVID-19 Symptoms in Older Adults: A Single-Center Study.
    Tosato M; Carfì A; Martis I; Pais C; Ciciarello F; Rota E; Tritto M; Salerno A; Zazzara MB; Martone AM; Paglionico A; Petricca L; Brandi V; Capalbo G; Picca A; Calvani R; Marzetti E; Landi F;
    J Am Med Dir Assoc; 2021 Sep; 22(9):1840-1844. PubMed ID: 34352201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review.
    Nasserie T; Hittle M; Goodman SN
    JAMA Netw Open; 2021 May; 4(5):e2111417. PubMed ID: 34037731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Year Health Outcomes in Hospitalized COVID-19 Survivors in China.
    Yang X; Hou C; Shen Y; Zhang M; Zhang K; Wang F; Liu Y; Ma X; Cheng L; Kang J; Hu B; Wang M; Zeng L; Wang Y; He Y; Cao G; Jiang J; Jones P; Cao B; Li L
    JAMA Netw Open; 2022 Sep; 5(9):e2231790. PubMed ID: 36107425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: A cohort study with 4 months median follow-up.
    Tleyjeh IM; Saddik B; AlSwaidan N; AlAnazi A; Ramakrishnan RK; Alhazmi D; Aloufi A; AlSumait F; Berbari E; Halwani R
    PLoS One; 2021; 16(12):e0260568. PubMed ID: 34874962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of post-acute COVID-19 syndrome among hospitalized severe COVID-19 patients: A 2-year follow-up study.
    Elias TP; Gebreamlak TW; Gebremeskel TT; Adde BL; Abie AS; Elias BP; Argaw AM; Tenaw AA; Belay BM
    PLoS One; 2024; 19(5):e0298409. PubMed ID: 38728331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent COVID-19 symptoms are highly prevalent 6 months after hospitalization: results from a large prospective cohort.
    Ghosn J; Piroth L; Epaulard O; Le Turnier P; Mentré F; Bachelet D; Laouénan C;
    Clin Microbiol Infect; 2021 Jul; 27(7):1041.e1-1041.e4. PubMed ID: 34125067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients.
    Fernández-de-Las-Peñas C; Rodríguez-Jiménez J; Cancela-Cilleruelo I; Guerrero-Peral A; Martín-Guerrero JD; García-Azorín D; Cornejo-Mazzuchelli A; Hernández-Barrera V; Pellicer-Valero OJ
    JAMA Netw Open; 2022 Nov; 5(11):e2242106. PubMed ID: 36378309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characterization of the Persistent COVID-19 Symptoms: A Descriptive Observational Study in Primary Care.
    Rodríguez Onieva A; Vallejo Basurte C; Fernández Bersabé A; Camacho Cerro L; Valverde Bascón B; Muriel Sanjuan N; Soto Castro CA; García Morales V; Piedra Ruiz F; Hidalgo Requena A
    J Prim Care Community Health; 2023; 14():21501319231208283. PubMed ID: 37947104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Select New Symptoms and Conditions Among Persons Aged Younger Than 20 Years and 20 Years or Older at 31 to 150 Days After Testing Positive or Negative for SARS-CoV-2.
    Hernandez-Romieu AC; Carton TW; Saydah S; Azziz-Baumgartner E; Boehmer TK; Garret NY; Bailey LC; Cowell LG; Draper C; Mayer KH; Nagavedu K; Puro JE; Rasmussen SA; Trick WE; Wanga V; Chevinsky JR; Jackson BR; Goodman AB; Cope JR; Gundlapalli AV; Block JP
    JAMA Netw Open; 2022 Feb; 5(2):e2147053. PubMed ID: 35119459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.
    Chen Y; Bai J
    Arch Gynecol Obstet; 2020 Sep; 302(3):545-551. PubMed ID: 32696241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Predictors of Persistent Symptoms After Clearance of SARS-CoV-2 Infection: A Multicenter Study from Egypt.
    Khalaf M; Alboraie M; Abdel-Gawad M; Abdelmalek M; Abu-Elfatth A; Abdelhamed W; Zaghloul M; ElDeeb R; Abdeltwab D; Abdelghani M; El-Raey F; Aboalam H; Badry A; Tharwat M; Afify S; Elwazzan D; Abdelmohsen AS; Fathy H; Wagih Shaltout S; Hetta HF; Bazeed SE
    Infect Drug Resist; 2022; 15():2575-2587. PubMed ID: 35619736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
    Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
    J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba.
    Molina-Águila N; Cruz-Rodríguez E; Ferrán-Torres RM; Galindo-Santana BM; López-Almaguer Y; Romero-Placeres M
    MEDICC Rev; 2021 Apr; 23(2):15. PubMed ID: 33974611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-Discharge Symptoms among Hospitalized COVID-19 Patients in Nigeria: A Single-Center Study.
    Ogoina D; James HI; Ogoinja SZ
    Am J Trop Med Hyg; 2021 Jul; 105(3):731-736. PubMed ID: 34270448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-COVID Diseases during the Pandemic: Where Have All Other Emergencies Gone?
    Ojetti V; Covino M; Brigida M; Petruzziello C; Saviano A; Migneco A; Candelli M; Franceschi F
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33019514
    [No Abstract]   [Full Text] [Related]  

  • 17. The Prevalence of COVID-19 Fog and the Impact on Quality of Life After SARS-CoV-2 Infection (QoL-COVID): A Cross Sectional Study.
    Rego de Figueiredo I; Branco Ferrão J; Dias S; Drummond Borges D; Fernandes J; Bernardino V; Gruner H; Panarra A
    Acta Med Port; 2023 Oct; 36(10):631-638. PubMed ID: 36790319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-COVID-19 Syndrome: Nine Months after SARS-CoV-2 Infection in a Cohort of 354 Patients: Data from the First Wave of COVID-19 in Nord Franche-Comté Hospital, France.
    Zayet S; Zahra H; Royer PY; Tipirdamaz C; Mercier J; Gendrin V; Lepiller Q; Marty-Quinternet S; Osman M; Belfeki N; Toko L; Garnier P; Pierron A; Plantin J; Messin L; Villemain M; Bouiller K; Klopfenstein T
    Microorganisms; 2021 Aug; 9(8):. PubMed ID: 34442798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal testing for severe acute respiratory syndrome coronavirus 2 in 2 Philadelphia hospitals: carrier prevalence and symptom development over 2 weeks.
    Bender WR; Hirshberg A; Coutifaris P; Acker AL; Srinivas SK
    Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100226. PubMed ID: 32954248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features and predictors of severity in 1022 adults with COVID-19].
    Saldías Peñafiel F; Peñaloza Tapia A; Farías Nesvadba D; Farcas Oksenberg K; Reyes Sánchez A; Cortés Meza J; Lara Hernández B; Aguilera Fuenzalida P; Leiva Rodríguez I
    Rev Med Chil; 2020 Oct; 148(10):1387-1397. PubMed ID: 33844708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.